info@seagull-health.com
SeagullHealth
语言:
search
new
Precautions for the use of Mavacamten Capsules
501
Article source: Seagull Pharmacy
Jul 14, 2025

The incidence of obstructive hypertrophic cardiomyopathy is gradually increasing, and the launch of Mavacamten Capsules provides a new treatment for such patients. As an effective cardiomyopathy treatment drug, it can reduce myocardial hypertrophy and heart obstruction. So, what are the precautions for the use of Mavacamten Capsules?

Precautions for the use of Mavacamten Capsules

The following are the precautions for the use of Mavacamten Capsules. Please consult a professional doctor for the specific medication process.

Take the medicine as prescribed by the doctor

Patients should take the medicine strictly according to the doctor's instructions and do not change the dose or stop using it on their own. The initial dose is usually 10 mg per day, but the doctor may gradually adjust the dose according to the patient's response, with a maximum dose of no more than 20 mg per day.

Regular follow-up

Patients should have regular medical follow-up so that the doctor can monitor the effect and safety of the treatment. This includes tests such as cardiac ultrasound to assess heart health.

Pay attention to adverse reactions

Mavacamten may cause some adverse reactions, such as dizziness, headache, gastrointestinal discomfort, arrhythmia, hypotension, and muscle weakness. If serious adverse reactions occur, such as difficulty breathing, you should seek medical attention immediately. Pregnant women, breastfeeding women, and patients who are allergic to Mavacamten or its ingredients are prohibited from using this drug.

Before starting Mavacamten, patients should inform their doctors of all medications they are currently taking, including prescription drugs, over-the-counter drugs, and supplements, as drug interactions may cause adverse reactions.

Daily care for patients with cardiomyopathy

Daily care for patients with cardiomyopathy is a comprehensive task, mainly including the following aspects:

Reasonable diet

Patients with cardiomyopathy should pay attention to dietary adjustments and choose low-salt, low-fat, high-protein foods rich in vitamins and minerals, such as lean meat, fish, eggs, fresh vegetables and fruits. At the same time, avoid eating foods that are too salty, high in fat and high in cholesterol to reduce the burden on the heart and the risk of cardiovascular disease.

Appropriate exercise

Depending on their physical condition, patients with cardiomyopathy can choose mild to moderate aerobic exercises such as walking, jogging, and Tai Chi to enhance myocardial function and improve their body resistance. The intensity and time of exercise should be gradually increased to avoid excessive fatigue, and stop exercising immediately when uncomfortable symptoms such as palpitations and shortness of breath occur.

Regular work and rest

Patients with cardiomyopathy should maintain a regular work and rest schedule, sleep no less than 7-8 hours a day, avoid staying up late and overwork, and develop good sleeping habits to maintain the body's normal metabolism and physiological functions and reduce the burden on the heart.

Patients with cardiomyopathy should pay attention to avoid infection, have regular checkups, and actively cooperate with doctors' treatment. Through reasonable daily care, patients with cardiomyopathy can improve their quality of life and delay the progression of the disease.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Mavacamten(Camzyos)
Mavacamten(Camzyos)
CAMZYOS (mavacamten) is specifically indicated for the treatment of adult...
WeChat Scan
Free Inquiry
Recommended Articles
Purchase channels for Mavacamten
Mavacamten is an innovative drug for the treatment of obstructive hypertrophic cardiomyopathy and has received widespread attention in recent years. This article will provide patients and their f...
How much does a box of Mavacamten capsules cost
Mavacamten capsules have a place in the treatment of obstructive hypertrophic cardiomyopathy with their significant therapeutic effects. As a new drug, it can not only improve heart function, but...
What is Camzyos?
Camzyos (Mavacamten) is an innovative drug designed for adults with symptomatic obstructive hypertrophic cardiomyopathy (HCM). As the first FDA-approved cardiac myosin inhibitor, Camzyos brings new ho...
Instructions for use of Mavacamten
Mavacamten is an innovative drug for the treatment of obstructive hypertrophic cardiomyopathy, developed by MyoKardia, a subsidiary of Bristol-Myers Squibb. The drug improves patient symptoms by regul...
What are the common side effects of Mavacamten capsule?
Mavacamten capsule is a drug for the treatment of obstructive hypertrophic cardiomyopathy. It improves heart function, relieves symptoms and improves the quality of life of patients by reducing t...
What is the name of Camzyos?
Camzyos, developed by a subsidiary of Bristol-Myers Squibb, has been approved in many countries around the world. Camzyos targets the root cause of hypertrophic cardiomyopathy and significantly improv...
Drug information of Mavacamten capsules: effects, dosage, and precautions
Clinical trials have shown that Mavacamten capsules can significantly reduce the degree of myocardial hypertrophy, improve cardiac function, and reduce cardiac symptoms such as chest tightne...
Instructions for rivastigmine transdermal patch (Exelon): indications, dosage, side effects and precautions
Clinical studies have shown that rivastigmine transdermal patch can significantly improve cognitive scores and daily executive functions of patients with dementia, delay disease progression, and is an...
Related Articles
Dosage and Administration of CAMZYOS
CAMZYOS is a drug used to treat obstructive hypertrophic cardiomyopathy. Its main function is to reduce the number of myosin heads that can effectively interact with actin, thereby reducing left ventr...
Is Mavacamten (CAMZYOS) available in China? How to buy it?
Mavacamten (CAMZYOS) is a first-in-class, orally active, selective cardiac myosin allosteric modulator, also known as a selective allosteric and reversible inhibitor of cardiac myosin. It mainly targe...
Is Mavacamten (CAMZYOS) expensive? How much does a box cost?
Mavacamten (CAMZYOS) is a drug used to treat symptomatic obstructive hypertrophic cardiomyopathy (obstructive HCM). Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by abnormal thick...
Mavacamten (CAMZYOS):Clinical Uses, Recommended Dosage, Treatment Effect
Mavacamten (CAMZYOS) is a small-molecule modulator of cardiac myosin, mainly used for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten (...
What are the indications for Mavacamten (CAMZYOS)
Mavacamten (CAMZYOS) is a reversible actin inhibitor, mainly used for the treatment of obstructive hypertrophic cardiomyopathy (HCM).What are the indications for Mavacamten (CAMZYOS) Since the me...
Precautions for Mavacamten (CAMZYOS)
Mavacamten (CAMZYOS), as an emerging myocardial myosin inhibitor, has shown significant efficacy in the treatment of obstructive hypertrophic cardiomyopathy (HCM). However, when using this medication,...
Drug information of Mavacamten capsules: effects, dosage, and precautions
Clinical trials have shown that Mavacamten capsules can significantly reduce the degree of myocardial hypertrophy, improve cardiac function, and reduce cardiac symptoms such as chest tightne...
What is the name of Camzyos?
Camzyos, developed by a subsidiary of Bristol-Myers Squibb, has been approved in many countries around the world. Camzyos targets the root cause of hypertrophic cardiomyopathy and significantly improv...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved